Euronext Paris & DBV Technologies

Euronext Paris: DBV Technologies' ordinary shares are traded on Euronext Paris, indicating its presence in European markets.

DBV Technologies: DBV Technologies will participate in the Goldman Sachs 47th Annual Global Healthcare Conference, providing an opportunity to present its developments and potentially attract investor interest.

Euronext Paris: DBV Technologies' ordinary shares are traded on Euronext Paris.

DBV Technologies: DBV Technologies announced the screening of the first participant in its THRIVE Phase 2 clinical study for the VIASKIN Peanut Patch, which could significantly advance its product pipeline and market position if successful.

Euronext Paris: Euronext Paris is the exchange where DBV Technologies ordinary shares are traded. The event is a routine filing with no impact on Euronext Paris.

DBV Technologies: DBV Technologies is the issuer of the liquidity contract report, which is a routine disclosure. The report shows increased share holdings in the liquidity account but no significant change in market perception.

DBV Technologies: DBV Technologies is the company issuing the regulatory filing regarding its total number of shares and voting rights.